Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Internal Medicine
Dr. Richard N. Channick, MD
|
|
Give Review
Richard Channick works in the field of Internal Medicine. He studied medicine at Temple University School of Medicine. He has 1 awards "Regional Top Doctor". Richard Channick has written publications. He has 80 publications published with PubMed. The lastest publication is: 'Successful pulmonary thromboendarterectomy in two patients with sickle cell disease.' He accepts Medicare.
Publications
- Incident and prevalent cohorts with Pulmonary arterial hypertension: insight from SERAPHIN.
- Chronic thromboembolic pulmonary hypertension: evolution in management.
- Macitentan for the treatment of Pulmonary arterial hypertension.
- Reliance on end-expiratory wedge pressure leads to misclassification of Pulmonary hypertension.
- The Massachusetts General Hospital Pulmonary Embolism Response Team (MGH PERT): Creation of a Multidisciplinary Program to Improve Care of Patients With Massive and Su...
- Oral therapies for Pulmonary arterial hypertension: endothelin receptor antagonists and phosphodiesterase-5 inhibitors.
- Recommendations for screening and detection of connective-tissue disease associated Pulmonary arterial hypertension.
- Reduction of Pulmonary arterial hypertension (pah)-related hospitalizations with macitentan in the randomized controlled trial seraphin.
- Circulating angiogenic modulatory factors predict survival and functional class in Pulmonary arterial hypertension.
- A multicenter, retrospective study of patients with Pulmonary arterial hypertension transitioned from parenteral prostacyclin therapy to inhaled iloprost.
- Combination therapy in Pulmonary arterial hypertension.
- Contemporary trends in the diagnosis and management of Pulmonary arterial hypertension: an initiative to close the care gap.
- Rapid transition from inhaled iloprost to inhaled treprostinil in patients with Pulmonary arterial hypertension.
- Postradiofrequency ablation inflammatory pseudotumor associated with Pulmonary venoocclusive disease: case report and review of the literature.
- Long-term effects of inhaled treprostinil in patients with Pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arte...
- Efficacy of Methylprednisolone in Preventing Lung Injury Following Pulmonary Thromboendarterectomy.
- Addition of inhaled treprostinil to oral therapy for Pulmonary arterial hypertension: a randomized controlled clinical trial.
- Updated clinical classification of Pulmonary hypertension.
- Diagnosis, assessment, and treatment of non-Pulmonary arterial hypertension Pulmonary hypertension.
- A functional single-nucleotide polymorphism in the TRPC6 gene promoter associated with idiopathic Pulmonary arterial hypertension.
- Hemodynamics and epoprostenol use are associated with thrombocytopenia in Pulmonary arterial hypertension.
- Exercise in patients with Pulmonary arterial hypertension.
- Central venous blood oxygen saturation monitoring in patients with Chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with me...
- Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic Pulmonary arterial hypertension.
- Randomized study of adding inhaled iloprost to existing bosentan in Pulmonary arterial hypertension.
- Is methamphetamine use associated with idiopathic Pulmonary arterial hypertension?
- Safety and efficacy of inhaled treprostinil as add-on therapy to bosentan in Pulmonary arterial hypertension.
- Endothelin antagonism in Pulmonary arterial hypertension.
- Endothelin receptor antagonists in Pulmonary arterial hypertension.
- Comparison of impedance cardiography to direct Fick and thermodilution cardiac output determination in Pulmonary arterial hypertension.
- Preoperative partitioning of pulmonary vascular resistance correlates with early outcome after thromboendarterectomy for Chronic thromboembolic pulmonary hypertension.
- Pulmonary endarterectomy: experience and lessons learned in 1,500 cases.
- Successful withdrawal of long-term epoprostenol therapy for Pulmonary arterial hypertension.
- Decreased plasma neurohormones and improved cardiac performance after surgical treatment of Chronic pulmonary embolism.
- Effects of the dual endothelin receptor antagonist bosentan in patients with Pulmonary arterial hypertension: a 1-year follow-up study.
- Rituximab treatment of Pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report.
- Combination of bosentan with epoprostenol in Pulmonary arterial hypertension: BREATHE-2.
- Surgical treatments/interventions for Pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.
- Continuous intravenous epoprostenol for Chronic thromboembolic pulmonary hypertension.
- Chronic thromboembolic pulmonary hypertension.
- Improvement in Pulmonary hypertension and hypoxemia during nitric oxide inhalation in a patient with end-stage Pulmonary fibrosis.
- Inhaled nitric oxide reverses hypoxic Pulmonary vasoconstriction in dogs. A practical nitric oxide delivery and monitoring system.
- Experience and results with 150 Pulmonary thromboendarterectomy operations over a 29-month period.
- Parenchymal scarring is associated with restrictive spirometric defects in patients with Chronic thromboembolic pulmonary hypertension.
- Unilateral Pulmonary artery thrombotic occlusion: is distal arteriopathy a consequence?
- Pulsed delivery of inhaled nitric oxide to patients with primary Pulmonary hypertension: an ambulatory delivery system and initial clinical tests.
- Right ventricular pathology in Chronic pulmonary hypertension.
- Inhaled nitric oxide (40 ppm) during one-lung ventilation, in the lateral decubitus position, does not decrease Pulmonary vascular resistance or improve oxygenation in...
- Accuracy of MR angiography compared with radionuclide scanning in identifying the cause of Pulmonary arterial hypertension.
- Successful Pulmonary thromboendarterectomy in two patients with sickle cell disease.
- Evaluation of patients with suspected Chronic thromboembolic pulmonary hypertension.
- Long-term outcome after Pulmonary thromboendarterectomy.
- Atrial septostomy as a bridge to lung transplantation in patients with severe Pulmonary hypertension.
- Identifying the cause of unilateral hypoperfusion in patients suspected to have Chronic pulmonary thromboembolism: diagnostic accuracy of helical CT and conventional a...
- Reoperative Pulmonary thromboendarterectomy.
- Combination therapy for Pulmonary hypertension: a glimpse into the future?
- The natural history of acute and Chronic thromboembolic disease: the search for the missing link.
- Endothelin mediates pulmonary vascular remodelling in a canine model of Chronic embolic pulmonary hypertension.
- The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing Pulmonary thromboendarterectomy.
- Pulmonary vascular remodeling distal to Pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase.
- "High probability" perfusion lung scans in Pulmonary venoocclusive disease.
- A new era in the treatment of primary Pulmonary hypertension.
- Pulmonary vasoreactivity in PPH.
- New and experimental therapies for Pulmonary hypertension.
- Effects of the dual endothelin-receptor antagonist bosentan in patients with Pulmonary hypertension: a randomised placebo-controlled study.
- Outpatient inhaled nitric oxide in a patient with idiopathic Pulmonary fibrosis: a bridge to lung transplantation.
- Single arterial occlusion to locate resistance in patients with Pulmonary hypertension.
- Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with Pulmonary arterial hypertension.
- Beraprost therapy for Pulmonary arterial hypertension.
- Bosentan.
- Diagnosis and treatment of Pulmonary arterial hypertension.
- Nitric oxide pathway and phosphodiesterase inhibitors in Pulmonary arterial hypertension.
- Complications associated with thoracentesis. A prospective, randomized study comparing three different methods.
- Temporal trends and drug exposures in Pulmonary hypertension: an American experience.
- Amplatzer device closure of a tortuous Gerbode (left ventricle-to-right atrium) defect complicated by transient hemolysis in an octogenarian.
- Sickle cell disease-associated Pulmonary hypertension: a coat of many colors.
- Inhaled treprostinil: a therapeutic review.
- The Pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated ...
- Sildenafil for Pulmonary arterial hypertension.
Schools
Temple University
University Of Ma Med Center
Procedures Preformed
- Bronchoscopy
- Thoracentesis
- Ventilation Management
Conditions Treated
- Acidosis
- Alkalosis
- Asbestosis
- Asthma
- View All
Doctors Specialties
- Critical Care Medicine
- Pulmonology
- Internal Medicine
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
University of Massachusetts -
Temple University School of Medicine
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1144255886 | |
| NPPES Provider LastName | CHANNICK | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Pulmonary Disease | |
| Total Claim Count | 1265.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 1.11 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1144255886 |
| Last Name Of The Provider | CHANNICK |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Chetan Seshadri, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David L. Stahl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy K. Dickey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna E. Moniodis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela J. Frank, MD |
|
|
Dr. Dena Noghrehkar, MD |
|
|
Dr. Jennifer T. Higa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James W. Weiss, MD |
|
|
Dr. David P. Delaney, MD |
|
|
Dr. Alexandra F. Cist, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lipi Roy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Haven R. Garber, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chester A. Alper, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew M. Schutzbank, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth S. Klings, MD
This Doctor is OpenDoctor Recommended.
|